| ATCC 17748| DSM 20735| NCTC 11831| Veillonella alcalescens subsp. dispar| Veillonella dispar| Veillonella dispar (Rogosa 1965) Mays et al. 1982
Oral health: Veillonella species are prevalent in the oral cavity and are associated with dental plaque and oral biofilms. While Veillonella are generally considered commensal bacteria, they can contribute to oral health issues when present in excessive amounts or in association with other pathogenic bacteria. Veillonella spp. have been found in dental caries (cavities), periodontal disease, and other oral infections, although their specific roles in these conditions are not fully understood.
Respiratory infections: Veillonella species, including Veillonella dispar, have been occasionally implicated in respiratory infections, particularly in individuals with underlying respiratory conditions or compromised immune systems. In some cases, Veillonella spp. have been isolated from respiratory specimens, such as sputum or bronchoalveolar lavage fluid, in patients with pneumonia, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. However, their significance as pathogens in respiratory infections is not well-established.
Gastrointestinal health: Veillonella species are common constituents of the human gut microbiota, particularly in the colon, where they ferment lactate and other organic acids produced by other gut bacteria. Veillonella spp. are involved in the metabolism of lactate and cross-feeding interactions with other gut microbes. While Veillonella are generally considered beneficial members of the gut microbiota, alterations in their abundance or composition have been observed in gastrointestinal conditions such as inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and colorectal cancer.
Metabolic interactions: Veillonella species, including Veillonella dispar, are known to participate in metabolic interactions with other members of the gut microbiota. They metabolize lactate to produce short-chain fatty acids (SCFAs) such as acetate and propionate, which can have systemic effects on host metabolism, immune function, and gut barrier integrity. Veillonella spp. have been implicated in the metabolism of dietary fibers and carbohydrates, contributing to the overall metabolic activity of the gut microbiota.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.41 | 6 | 8770 | 0 | 4844 | 879.3 | 78 | 2022.6 | 0 | 1060 | 0 %ile | 100 %ile | ||
biomesight | 57.21 | 0 | 60 | 10 | 360 | 0 | 10332 | 800.1 | 70 | 4863.2 | 0 | 370 | 3.9 %ile | 90.2 %ile |
thorne | 82.76 | 1 | 87 | 0 | 59 | 17.1 | 10 | 21.3 | 0 | 30 | 0 %ile | 100 %ile | ||
thryve | 63.9 | 0 | 130 | 27 | 863 | 0 | 29572 | 2841.5 | 124 | 13638 | 0 | 972 | 11.1 %ile | 90.3 %ile |
ubiome | 0.25 | 101 | 21197 | 0 | 39887 | 10649 | 10649 | 14917.1 | 101 | 21197 | 25 %ile | 50 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 0 | 0.57 | 0 | 0.0001 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 61.453 % | 0.075 % | 0.447 % | 1760.0 | 2864 |
BiomeSightRdp | 25 % | 0.012 % | 0.012 % | 8.0 | 32 |
CerbaLab | 66.667 % | 0.004 % | 0.005 % | 2.0 | 3 |
CosmosId | 34.375 % | 0.141 % | 0.271 % | 11.0 | 32 |
custom | 8.475 % | 0.043 % | 0.028 % | 5.0 | 59 |
Medivere | 71.429 % | 0.069 % | 0.131 % | 5.0 | 7 |
Microba | 3.571 % | 0.677 % | % | 1.0 | 28 |
Thorne | 71.591 % | 0.017 % | 0.108 % | 63.0 | 88 |
Thryve | 65.076 % | 0.296 % | 1.315 % | 900.0 | 1383 |
uBiome | 0.253 % | 1.065 % | 1.492 % | 2.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.